Far UV-C lights and fiber optics induced and selective far UV-C treatment against COVID-19 for fatality-survival tradeoff
Preprint
- 27 April 2020
- preprint
- Published by Institute of Electrical and Electronics Engineers (IEEE) in TechRxiv
Abstract
This work focuses on the usability of Ultraviolet (UV) on humans as an economical way of contesting against COVID-19. Specifically, far-UVC is presented as a promising candidate against COVID-19 since it can inactivate pathogens including viruses and bacteria without harming mammalian skin or eyes. Furthermore, the work also points out the applicability of far-UVC lights for public spaces and treatment of selective region in COVID-19 patients by using fiberoptic as the medium for high-risk cases where chances of survival are low and such treatment may avoid fatality due to the COVID-19.Keywords
All Related Versions
This publication has 11 references indexed in Scilit:
- COVID-19 and Italy: what next?The Lancet, 2020
- DNA Damage Kills Bacterial Spores and Cells Exposed to 222-Nanometer UV RadiationApplied and Environmental Microbiology, 2020
- Q&A: The novel coronavirus outbreak causing COVID-19BMC Medicine, 2020
- A Clinical Trial Evaluating the Effects of Ultra-Violet C treatment (UVC) during Ex Vivo Lung Perfusion (EVLP) as a Method of Inactivating Hepatitis C Infection in Donor LungsThe Journal of Heart and Lung Transplantation, 2019
- Effect of far ultraviolet light emitted from an optical diffuser on methicillin-resistant Staphylococcus aureus in vitroPLOS ONE, 2018
- Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseasesScientific Reports, 2018
- Far-UVC light applications: sterilization of MRSA on a surface and inactivation of aerosolized influenza virus2018
- Ultraviolet Irradiation of Blood: “The Cure That Time Forgot”?2017
- Histological and ultrastructural analyses of mole rats lung cells exposed to ultraviolet radiationJournal of Radiation Research and Applied Sciences, 2014
- 207-nm UV Light - A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro StudiesPLOS ONE, 2013